These characteristics may provide insight regarding the mechanisms for the relatively aggressive biology of ALK-rearranged lung cancer, as well as potential therapeutic strategies to overcome resistance to ALK inhibitors and prevent EMT-mediated metastasis. This evidence concerns the gene ALK and lung carcinoma.